European Journal of Cancer
Volume 41, Issue 13 , Pages 1969-1979, September 2005

Mechanisms and preclinical efficacy of silibinin in preventing skin cancer

  • Rana P. Singh

      Affiliations

    • Department of Pharmaceutical Sciences, School of Pharmacy, University of Colorado at Denver and Health Sciences Center, 4200 East Ninth Avenue, Box C238, Denver, CO 80262, United States
    • ,
  • Rajesh Agarwal

      Affiliations

    • Department of Pharmaceutical Sciences, School of Pharmacy, University of Colorado at Denver and Health Sciences Center, 4200 East Ninth Avenue, Box C238, Denver, CO 80262, United States
    • University of Colorado Cancer Center, University of Colorado at Denver and Health Sciences Center, Denver, CO 80262, United States
    • Corresponding Author InformationCorresponding author. Tel.: +1 303 315 1381; fax: +1 303 315 6281.

Received 2 March 2005; received in revised form 10 March 2005; accepted 18 March 2005.

Full Text Available

  • Purchase this article for  31.50 USD

    Access is available for 24 hours.

    (Login or Register to purchase)

  • Subscribe to this title
  • Claim access now

    Current subscribers


    • PII: S0959-8049(05)00474-0

    doi:10.1016/j.ejca.2005.03.033

    European Journal of Cancer
    Volume 41, Issue 13 , Pages 1969-1979, September 2005